Literature DB >> 25169049

Finding degrees of separation: experimental approaches for astroglial and oligodendroglial cell isolation and genetic targeting.

Li-Jin Chew1, Cynthia A DeBoy2, Vladimir V Senatorov3.   

Abstract

The study of CNS glial cell function requires experimental methods to detect, purify, and manipulate each cell population with fidelity and specificity. With the identification and cloning of cell- and stage-specific markers, glial cell analysis techniques have grown beyond physical methods of tissue dissociation and cell culture, and become highly specific with immunoselection of cell cultures in vitro and genetic targeting in vivo. The unique plasticity of glial cells offers the potential for cell replacement therapies in neurological disease that utilize neural cells derived from transplanted neural stem and progenitor cells. In this mini-review, we outline general physical and genetic approaches for macroglial cell generation. We summarize cell culture methods to obtain astrocytes and oligodendrocytes and their precursors, from developing and adult tissue, as well as approaches to obtain human neural progenitor cells through the establishment of stem cells. We discuss popular targeting rodent strains designed for cell-specific detection, selection and manipulation of neuroglial cell progenitors and their committed progeny. Based on shared markers between astrocytes and stem cells, we discuss genetically modified mouse strains with overlapping expression, and highlight SOX-expressing strains available for targeting of stem and progenitor cell populations. We also include recently established mouse strains for detection, and tag-assisted RNA and miRNA analysis. This discussion aims to provide a brief overview of the rapidly expanding collection of experimental approaches and genetic resources for the isolation and targeting of macroglial cells, their sources, progeny and gene products to facilitate our understanding of their properties and potential application in pathology.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Astrocytes; Cell purification; Genetic targeting; Neural precursor; Oligodendroglia; Transgenic mice

Mesh:

Year:  2014        PMID: 25169049      PMCID: PMC4171043          DOI: 10.1016/j.jneumeth.2014.08.017

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  357 in total

1.  Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.

Authors:  S Hisahara; T Araki; F Sugiyama; K i Yagami; M Suzuki; K Abe; K Yamamura; J Miyazaki; T Momoi; T Saruta; C C Bernard; H Okano; M Miura
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 2.  Genetic approaches to study glial cells in the rodent brain.

Authors:  Frank W Pfrieger; Michal Slezak
Journal:  Glia       Date:  2011-12-07       Impact factor: 7.452

3.  Origin of new glial cells in intact and injured adult spinal cord.

Authors:  Fanie Barnabé-Heider; Christian Göritz; Hanna Sabelström; Hirohide Takebayashi; Frank W Pfrieger; Konstantinos Meletis; Jonas Frisén
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

4.  GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS.

Authors:  Kristen B Casper; Ken D McCarthy
Journal:  Mol Cell Neurosci       Date:  2006-02-03       Impact factor: 4.314

5.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

6.  Expression of reef coral fluorescent proteins in the central nervous system of transgenic mice.

Authors:  Petra G Hirrlinger; Anja Scheller; Christian Braun; Markus Quintela-Schneider; Babette Fuss; Johannes Hirrlinger; Frank Kirchhoff
Journal:  Mol Cell Neurosci       Date:  2005-11       Impact factor: 4.314

7.  The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages.

Authors:  Hirohide Takebayashi; Yoko Nabeshima; Shosei Yoshida; Osamu Chisaka; Kazuhiro Ikenaka; Yo-ichi Nabeshima
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

8.  In vitro and in vivo effects on neural crest stem cell differentiation by conditional activation of Runx1 short isoform and its effect on neuropathic pain behavior.

Authors:  Nadezda Kanaykina; Klas Abelson; Dale King; Anna Liakhovitskaia; Silke Schreiner; Michael Wegner; Elena N Kozlova
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

9.  SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function.

Authors:  C Claus Stolt; Anita Schlierf; Petra Lommes; Simone Hillgärtner; Torsten Werner; Thomas Kosian; Elisabeth Sock; Nicoletta Kessaris; William D Richardson; Veronique Lefebvre; Michael Wegner
Journal:  Dev Cell       Date:  2006-11       Impact factor: 12.270

10.  Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.

Authors:  Jian Luo; Peggy Ho; Lawrence Steinman; Tony Wyss-Coray
Journal:  J Neuroinflammation       Date:  2008-02-01       Impact factor: 8.322

View more
  4 in total

Review 1.  Lineage, fate, and fate potential of NG2-glia.

Authors:  Akiko Nishiyama; Linda Boshans; Christopher M Goncalves; Jill Wegrzyn; Kiran D Patel
Journal:  Brain Res       Date:  2015-08-21       Impact factor: 3.252

Review 2.  Targeting human oligodendrocyte progenitors for myelin repair.

Authors:  Karen C Dietz; Jessie J Polanco; Suyog U Pol; Fraser J Sim
Journal:  Exp Neurol       Date:  2016-03-18       Impact factor: 5.330

3.  Rapid and Specific Immunomagnetic Isolation of Mouse Primary Oligodendrocytes.

Authors:  Rafael E Flores-Obando; Mona M Freidin; Charles K Abrams
Journal:  J Vis Exp       Date:  2018-05-21       Impact factor: 1.355

Review 4.  In vitro Models of Neurodegenerative Diseases.

Authors:  Anna Slanzi; Giulia Iannoto; Barbara Rossi; Elena Zenaro; Gabriela Constantin
Journal:  Front Cell Dev Biol       Date:  2020-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.